Autonomix Medical Common Stock Analysis

Autonomix Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.59. Some equities with similar Price to Book (P/B) outperform the market in the long run. Autonomix Medical Common recorded a loss per share of 4.51. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 25th of October 2024. For more info on Autonomix Medical Common please contact Bradley Hauser at 713 588 6150 or go to https://autonomix.com.

Autonomix Medical Common Investment Alerts

Autonomix Largest EPS Surprises

View All Earnings Estimates

Autonomix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.71 M.

Autonomix Profitablity

Management Efficiency

Autonomix Medical Common has return on total asset (ROA) of (1.5931) % which means that it has lost $1.5931 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5241) %, meaning that it created substantial loss on money invested by shareholders. Autonomix Medical's management efficiency ratios could be used to measure how well Autonomix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.1 in 2026. Return On Capital Employed is likely to drop to -1.35 in 2026. Non Current Assets Total is likely to rise to about 237.9 K in 2026, whereas Total Assets are likely to drop slightly above 6.1 M in 2026.

Technical Drivers

As of the 3rd of January, Autonomix Medical shows the Risk Adjusted Performance of (0.04), standard deviation of 9.24, and Mean Deviation of 5.17. Autonomix Medical Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Autonomix Medical Common Price Movement Analysis

Autonomix Medical Common Insider Trading Activities

Autonomix Medical Outstanding Bonds

Autonomix Medical Predictive Daily Indicators

Autonomix Medical Forecast Models

Autonomix Medical's time-series forecasting models are one of many Autonomix Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Autonomix Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Autonomix Medical Bond Ratings

Autonomix Medical Common financial ratings play a critical role in determining how much Autonomix Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Autonomix Medical's borrowing costs.

Autonomix Medical Total Assets Over Time

Autonomix Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Autonomix Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Autonomix Medical Debt Ratio

8.8

It appears most of the Autonomix Medical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Autonomix Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Autonomix Medical, which in turn will lower the firm's financial flexibility.

Autonomix Medical Corporate Bonds Issued

Autonomix Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Autonomix Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Autonomix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Autonomix Medical. By using and applying Autonomix Stock analysis, traders can create a robust methodology for identifying Autonomix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Autonomix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Autonomix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Autonomix Medical Common stock analysis indicators help investors evaluate how Autonomix Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Autonomix Medical shares will generate the highest return on investment. By understating and applying Autonomix Medical stock analysis, traders can identify Autonomix Medical position entry and exit signals to maximize returns.

When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.